These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18322439)

  • 1. Novel targets for systemic therapy of colorectal cancer.
    Kopetz S
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):38-40. PubMed ID: 18322439
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances and challenges in the use of biomarkers in clinical trials.
    Chabner B
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):42-3. PubMed ID: 18322440
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term prognosis for colorectal carcinoma treated with adjuvant immunochemotherapy].
    Sakai T; Yamashita Y
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():460-3. PubMed ID: 14574935
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancers of the large bowel and hepatobiliary tract.
    Treat J; Woolley PV
    Cancer Chemother Biol Response Modif; 1993; 14():467-79. PubMed ID: 8312115
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.
    Dizon DS; Schwartz J; Kemeny N
    Surg Oncol Clin N Am; 2008 Oct; 17(4):759-71, viii. PubMed ID: 18722916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
    Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
    J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.
    Takahari D; Yamada Y; Okita NT; Honda T; Hirashima Y; Matsubara J; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Oncology; 2009; 76(1):42-8. PubMed ID: 19033715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer.
    Garattini L; Compadri PD; Koleva D; Pasina L; Nobili A
    J Med Econ; 2008; 11(1):177-97. PubMed ID: 19450119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biomarker for chemotherapy in patients with colorectal cancer].
    Matsusaka S
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors of tyrosine kinase: waiting for the good news in colorectal cancer as well.
    Sobrero A; Andretta V
    Onkologie; 2008 May; 31(5):224-5. PubMed ID: 18497509
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.
    Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Balaguer F; Sempere L; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Pons E; Payá A; Alenda C;
    Eur J Cancer; 2009 Feb; 45(3):365-73. PubMed ID: 18722765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies of the modulation of Ftorafur.
    Creaven PJ; Rustum YM; Petrelli NJ; Gorbunova VA
    Adv Exp Med Biol; 1993; 339():253-62; discussion 263. PubMed ID: 8178722
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Sézary syndrome with bexarotene after IFNalpha and methotrexate failure.
    Bagot M
    Dermatol Clin; 2008 Jan; 26 Suppl 1():27-9. PubMed ID: 18405184
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
    Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R
    Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mechanisms and therapeutic potential of curcumin for colorectal cancer.
    Villegas I; Sánchez-Fidalgo S; Alarcón de la Lastra C
    Mol Nutr Food Res; 2008 Sep; 52(9):1040-61. PubMed ID: 18655004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer and diabetes: are there similarities?
    Oldham RK
    Mol Biother; 1990 Sep; 2(3):130-1. PubMed ID: 2222895
    [No Abstract]   [Full Text] [Related]  

  • 18. New drugs for colorectal cancer.
    Hoff PM
    Cancer Chemother Biol Response Modif; 2003; 21():817-29. PubMed ID: 15338776
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxic chemotherapy for incurable colorectal cancer: living with a PICC-line.
    Molloy D; Smith LN; Aitchison T
    J Clin Nurs; 2008 Sep; 17(18):2398-407. PubMed ID: 18705719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
    Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
    Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.